Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
455.6 USD | +1.07% | +2.43% | +12.08% |
May. 22 | Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing | MT |
May. 21 | ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.08% | 116B | |
+12.82% | 106B | |
-9.80% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.49% | 16.33B | |
+6.90% | 14.14B | |
+31.34% | 12.02B | |
-2.15% | 7.58B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Wells Fargo Adjusts Price Target on Vertex Pharmaceuticals to $540 From $500, Maintains Overweight Rating